Bariatric Surgery Versus Non-alcoholic Steato-hepatitis
NCT03524365 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288
Last updated 2023-02-21
Summary
Bariatric-metabolic surgery is effective in treating the cluster of conditions forming the metabolic syndrome, strictly associated with NAFLD and NASH. Recently, we and other authors have shown also in the long term (up 5 years) with randomized-controlled trials (RCTs) that bariatric-metabolic surgery allows remission of type 2 diabetes and obesity reduction, which are the two major pathogenetic factors of NASH development, with maintenance of weight loss.
Few small and mainly retrospective studies have shown that bariatric surgery is effective in improving NASH histologic picture in obese subjects.
The aim of our proposal is to conduct a 3 arm single centre, superiority, RCT comparing Roux-en-Y Gastric Bypass (RYGB) with Sleeve Gastrectomy (SG) and with Intensive Lifestyle Modifications (ILM) for the treatment of Non-Alcoholic Steato-Hepatitis.
Conditions
- Non Alcoholic Steatohepatitis
Interventions
- PROCEDURE
-
RYGB
Roux-\&-Y Gastric Bypass (RYGB) involves the use of a surgical stapler to create a small and vertically oriented gastric pouch with a volume of 30 ml. The upper pouch is completely divided by the gastric remnant and is anastomosed to the jejunum, 75 cm distally to the Treitz's ligament , through a narrow gastrojejunal anastomosis in a Roux-en-Y fashion. Bowel continuity is restored by an entero-entero anastomosis, between the excluded biliary limb and the alimentary limb, performed at 100 cm from the gastrojejunostomy. Lifestyle modification counselling is provided to each patient.
- PROCEDURE
-
SG
The SG is created using a linear stapler with two sequential 4.8/60-mm green load firings for the antrum, followed by two or three sequential 3.5/60-mm blue loads for the remaining gastric corpus and fundus. The stapler is applied alongside a 48-Fr calibrating bougie. The resection line is performed avoiding the ''critical area'' by resecting the fundus 1.5 cm from the angle of His. Staple lines are buttressed with bovine pericardial strips. The resected stomach is grasped at the antral tip by a laparoscopic grasper and retrieved through one of the trocar sites. A methylene blue dye test by a nasogastric tube is routinely performed at the end of the procedure. The residual gastric remnant capacity is 60-80 ml. Drains are not routinely placed, and the nasogastric tube is removed at the end of the procedure. Upper gastrointestinal contrast (Gastrografin) study is performed on the first postoperative day. Lifestyle modification counselling is provided to each patient.
- OTHER
-
Intensive Lifestyle Modification
Resting calorie requirements will be calculated via the Harris Benedict equation (24) and an activity factor, and subjects will be instructed not to change their activity level other than that suggested by physicians during the study. The diet will contain 1/3 kcal less than the calculated energy expenditure and 30% fat of which 10% saturated, 55% lower glycemic index carbohydrates and 15% proteins. The participants will be encouraged to gradually increase their walking to achieve 10,000 steps per day. A moderate intensity physical activity program of 1 hour of aerobic exercise 2-3 hours per week will be recommended to all subjects. Their physical activity will be assessed by IPAQ-SF.
Sponsors & Collaborators
-
University of Roma La Sapienza
collaborator OTHER -
Catholic University of the Sacred Heart
lead OTHER
Principal Investigators
-
Geltrude Mingrone, MD PhD · Catholic University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-06
- Primary Completion
- 2022-07-20
- Completion
- 2022-07-20
Countries
- Italy
Study Locations
More Related Trials
-
Bariatric Surgery vs. Lifestyle Modification for NASH
NCT04298736 ·Status: UNKNOWN ·Phase: NA
-
Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery
NCT00834938 ·Status: COMPLETED
-
Durability of Weight Loss After Bariatric Surgery
NCT04650373 ·Status: COMPLETED
-
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
NCT03535142 ·Status: RECRUITING ·Phase: NA
-
Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity
NCT00545805 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Changes in Body Composition Following Bariatric Surgery
NCT02148068 ·Status: COMPLETED
-
Effectiveness of Bariatric Surgery for NAFLD/NASH
NCT04366999 ·Status: RECRUITING
-
Sleeve Gastrectomy: Outcome, Morbidity and Mortality. A Multicentric Retrospective Trial
NCT04643262 ·Status: ENROLLING_BY_INVITATION
-
Complications After Bariatric Surgery Based, a Questionnaire Survey
NCT01930851 ·Status: COMPLETED
-
Comparing the Benefits and Harms of Three Types of Weight Loss Surgery -- The PCORnet® Bariatric Study
NCT02741674 ·Status: COMPLETED
-
Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19
NCT04486417 ·Status: UNKNOWN
-
Who Will Benefit From Bariatric Surgery for Diabetes?
NCT03842475 ·Status: RECRUITING
-
Comparison of Gastric Bypass and Sleeve Gastrectomy in Metabolic and Cardiovascular Indices
NCT03851874 ·Status: COMPLETED ·Phase: NA
-
Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention
NCT01352403 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients
NCT03472157 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Phenotyping of Bariatric Surgery Patients
NCT02421055 ·Status: COMPLETED
-
Effect of Bariatric Surgery on Gut Hormones Production and Cure of Type 2 Diabetes Mellitus
NCT01251016 ·Status: UNKNOWN
-
Prevalence of Complications After Bariatric Surgery - an Epidemiologic Survey
NCT01930929 ·Status: COMPLETED
-
Dietary Fibers and Satiety in Bariatric Patients
NCT03573258 ·Status: COMPLETED ·Phase: NA
-
Metabolism and Bariatric Surgery Study
NCT03371368 ·Status: COMPLETED ·Phase: NA
-
Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome
NCT05408728 ·Status: ENROLLING_BY_INVITATION
-
Surgical Innovation for Diabetes Treatment 2
NCT04712409 ·Status: UNKNOWN ·Phase: NA
-
Outcomes of Sleeve Gastrectomy in Obese Patients, Retrospective Study.
NCT04967053 ·Status: COMPLETED
-
Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention
NCT03875625 ·Status: RECRUITING ·Phase: NA
-
Bariatric Surgery and HDL-cholesterol
NCT01707771 ·Status: COMPLETED ·Phase: NA